Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill shows promise for ulcerative colitis in major trial

NCT ID NCT05507216

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 2 times

Summary

This study tested a new daily pill, ABX464, for people with moderate to severe ulcerative colitis who did not get better with other treatments. About 636 adults and teens took either 25 mg, 50 mg, or a placebo for 8 weeks. The main goal was to see if the drug could help achieve remission, meaning fewer symptoms and less inflammation in the colon.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

636 people

The number who actually took part.

Started

Jan 2023

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men or women at least 16 years old; Adolescent subjects will only be enrolled if approved by the country regulatory/health authority. If these approvals have not been granted, only subjects ≥ 18 years old will be enrolled. To be eligible, adolescent subjects must weigh ≥ 40 kg and meet the definition of Tanner Stage 5 at the screening visit. * Subjects must understand, sign and date the written voluntary informed consent form at the visit prior to any protocol-specific procedures. For under-aged subjects, national requirements regarding consent should also be met. * Documented diagnosis of UC confirmed by endoscopy and histology. Should endoscopy/histology results not be available at screening, results from endoscopies and biopsies taken at screening may be used. * Active disease defined by modified Mayo score (MMS) ≥ 5 with rectal bleeding subscore (RBS) ≥ 1 and endoscopy subscore (MES) of 2 or 3 (confirmed by central reader). * Subjects with documented inadequate response (defined as lack of response or loss of response or intolerance) to at least one of the following treatments: corticosteroids, immunosuppressant, biologic or biosimilar therapies, S1P receptor modulators and/or JAK inhibitors and/or new drugs approved during the study (note: failure to only 5-ASA or sulfasalazine is not accepted). * Women of childbearing potential (WOCBP) subjects and male subjects with WOCBP partner must agree to comply with the contraception requirements described in the protocol. * Subjects able and willing to comply with study visits and procedures as per protocol. * Subjects should be affiliated to a health insurance policy whenever required by a participating country or state. Exclusion Criteria: * Subjects with UC limited to an isolated proctitis (≤ 15cm from anal verge) determined by endoscopy central reading. * Subjects with primary sclerosing cholangitis or autoimmune hepatitis. * Subjects who have failed on 5-ASA or sulfasalazine therapy only. * Subjects with CD or presence or history of fistula, indeterminate colitis, infectious/ischemic colitis or microscopic colitis (lymphocytic and collagenous colitis). * History or current evidence of toxic megacolon, fulminant colitis, bowel perforation. * History of colonic cancer or colonic low grade or high grade dysplasia adenomatous polyps, and/or at the screening endoscopy, evidence of colonic cancer or evidence of low grade or high grade dysplasia adenomatous polyps (fully removed or not). * Recent or planned bowel surgery or history of proctocolectomy or partial colectomy or current stoma. * Subjects on antidiarrheals including those working on motility (e.g., loperamide, diphenoxylate with atropine, etc.). * Subjects on probiotics (e.g., Culturelle® \[Lactobacillus GG, i-Health, Inc.\], Saccharomyces boulardii). * Subjects who do not meet the washout period requirements prior to the screening endoscopy. * Subjects with the following hematological and biochemical laboratory parameters obtained during the screening period: * Hemoglobin ≤ 8.0 g dL-1 * Absolute neutrophil count \< 750 mm-3 * Platelets \< 100,000 mm-3 * Creatinine clearance \< 60 mL.min-1 (Cockroft-Gault formula) * Total serum bilirubin \> 1.5 x ULN * Alkaline phosphatase, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \> 2 x ULN * Subjects with the following conditions (infection): * Subjects with chronic or recurrent grade 3 or grade 4 infection within the last 2 months prior to screening or a history of opportunistic infection while not on immunosuppressive therapy. * Herpes zoster reactivation within the last 2 months prior to screening. * Subjects with active infection at screening or any major episode of infection that required hospitalization or treatment with intravenous antibiotics within 1 month of screening or during screening. Fungal infection of nail beds is allowed. * Positive assay or stool culture for pathogens (ova and parasite examination, bacteria) or positive test for Clostridium difficile toxin at screening. If C. difficile is positive, subject may be treated and retested ≥ 2 weeks after completing treatment. * Subjects with HIV infection. * Subjects having acute or chronic hepatitis B infection at screening (positive for hepatitis B surface antigen \[HbsAg\], or negative for HbsAg and positive for anti-hepatitis B core antibody in conjunction with detectable HBV DNA, or detectable HBV DNA). * Subjects having acute or chronic hepatitis C infection at screening as defined by positive for hepatitis C antibody (subjects successfully treated and without recurrence ≥ 1 year with no detectable HCV RNA \[assessed centrally\] are eligible). * Active tuberculosis (TB) or untreated latent TB are ruled out. For subjects with positive or intermediate QuantiFERON test see the current study protocol. * Subjects with an uncontrolled ischemic heart disease and/or a history of congestive heart failure with New York Heart Association (NYHA) class 3 or 4 symptoms. * Subjects with a family or personal history of congenital or acquired long QT syndrome, or subjects with a marked baseline prolongation of QT/QTc interval (e.g., repeated demonstration of a QTc interval \[Fridericia or Bazett correction\] \>450 milliseconds for male and \> 460 milliseconds for female). * Subjects with a history of torsade de pointe (TdP). * Acute or chronic of clinically relevant pulmonary, hepatic, pancreatic or renal functional abnormality, encephalopathy, neuropathy or unstable central nervous system pathology such as seizure disorder, or any other clinically significant medical problems as determined by physical examination and/or laboratory screening tests and/or medical history (note: treated autoimmune hypothyroidy and autoimmune diabetes are allowed). * Serious illness requiring hospitalization within 4 weeks prior to screening (except UC flare). * Subjects previously treated with ABX464. * Subjects with a known hypersensitivity to the active substance or to any of the excipients. * WOCBP subject who is pregnant or breast-feeding at screening, or intends to become pregnant during the study, or male subject with WOCBP partner who intends to be pregnant during the study. * Illicit drug or alcohol abuse or dependence. * Subjects who received live vaccine within 3 months prior to screening and/or who's planning to receive such a vaccine during the study duration. * Use of any investigational or non-registered product within 3 months or within 5 half-lives preceding baseline, whichever is longer, and during the study. * Subjects committed to an institution by virtue of an order issued either by the judicial or the administrative authorities. * Any condition, which in the opinion of the investigator, could compromise the subject's safety or adherence to the study protocol.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ulcerative colitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • (G.I.R.I.) GI Research Institute

    Vancouver, British Columbia, V6Z 2K5, Canada

  • 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

    Lublin, 20-049, Poland

  • ALLMEDICA sp. z o. o.

    Nowy Targ, 34-400, Poland

  • AZ Delta

    Roeselare, 8800, Belgium

  • AZ Maria Middelares

    Ghent, 9000, Belgium

  • Accelerium S de RL de CV

    Monterrey, Nuevo León, 64000, Mexico

  • Accout Center s.r.o.

    Šahy, 93601, Slovakia

  • Acibadem City Clinic Mladost Eood

    Sofia, Bulgaria

  • Addenbrooke's Hospital

    Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom

  • Advanced Medical Research Center

    Port Orange, Florida, 32127, United States

  • AdventHealth Medical Group

    Orlando, Florida, 32804, United States

  • All India Institute of Medical Sciences

    New Delhi, National Capital Territory of Delhi, 110029, India

  • Aoyama Clinic

    Kobe, Hyōgo, 650-0015, Japan

  • Applied Research Center of Arkansas

    Little Rock, Arkansas, 72212, United States

  • Arnold Palmer Hospital For Children

    Orlando, Florida, 32806, United States

  • Asahikawa City Hospital

    Asahikawa-shi, Japan

  • Asahikawa Medical University Hospital

    Asahikawa-shi, Japan

  • Aso Co.,Ltd Iizuka Hospital

    Iizuka-shi, Fukuoka, 820-8505, Japan

  • Azienda Ospedale-Università di Padova

    Padova, Italy

  • Azienda Ospedaliero Universitaria Mater Domini

    Catanzaro, 88100, Italy

  • Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco)

    Milan, 20157, Italy

  • BVL Clinical Research

    Liberty, Missouri, 64068, United States

  • Beaumont Hospital

    Dublin, Ireland

  • CDC - Centro Digestivo de Curitiba

    Curitiba, Paraná, 80430-160, Brazil

  • CECIP - Centro de Estudos Clínicos do Interior Paulista

    Jaú, São Paulo, 17201-130, Brazil

  • CEMIC

    Buenos Aires, Ciudad Autonoma Buenos Aires, 1431, Argentina

  • CHU Amiens - Hopital Sud

    Amiens, Somme, 80054, France

  • CHU Lille - Hôpital Claude Huriez

    Lille, Nord, 59037, France

  • CHU Nice - Hôpital de l'Archet 2

    Nice, Alpes Maritimes, 06200, France

  • CHU Rennes - Hôpital Pontchaillou

    Rennes, Ille Et Vilaine, 35000, France

  • CHU de Grenoble - Hôpital Nord

    Grenoble, Isere, 38043, France

  • CNCE M.I.Pyrohov Vinnytsia Regional Clinical Hospital of Vinnytsia Regional Council

    Vinnytsia, Ukraine

  • CNCE Vinnytsia City Clinical Hospital #1, Dep of Clinical Therapy #2

    Vinnytsia, Ukraine

  • CNCE of Kyiv Regional Council Kyiv Regional Center of Rehabilitation Medicine

    Kyiv, Ukraine

  • CNCE of Kyiv Regional Council Kyiv Regional Clinical Hospital, Clinical Center of Therapeutic Profil

    Kyiv, Ukraine

  • CNCE of Lviv Regional Council Lviv Regional Clinical Hospital

    Lviv, Ukraine

  • CNE A.Novak Transcarpathian Reg Clin Hospital of Transcarpathian Reg Council

    Uzhhorod, Ukraine

  • CNE Odesa Regional Clinical Hospital of Odesa Regional Council

    Odesa, Ukraine

  • Carmel Medical Center

    Haifa, 34362, Israel

  • Centre Hospitalier Départemental Les Oudairies

    La Roche-sur-Yon, Vendée, 85925, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, Rhone, 69495, France

  • Centro Medico Teknon

    Barcelona, 08022, Spain

  • Centro de Investigacion CICE

    San Miguel de Tucumán, Tucumán Province, 4000, Argentina

  • Centro de Investigaciones Clinicas Baigorria

    Rosario, Santa Fe Province, Argentina

  • Centro de Investigaciones Medicas Tucuman

    San Miguel de Tucumán, Tucumán Province, T4000AXL, Argentina

  • Centrum Medyczne Plejady

    Krakow, 30-363, Poland

  • Centrum Medyczne Plejady

    Krakow, Poland

  • Centrum Medyczne Pratia Gdynia

    Gdynia, 81-338, Poland

  • Centrum Zdrowia Tuchow Sp. z o.o.

    Wierzchosławice, 33-122, Poland

  • Chaim Sheba Medical Center

    Ramat Gan, 5265602, Israel

  • Charité - Campus Charité Mitte

    Berlin, 10117, Germany

  • Citrus Valley Gastroenterology

    Covina, California, 91723, United States

  • Cliagen - Clinica de Atencao em Gastroenterologia, Especialidades e Nutricao

    Salvador, Estado de Bahia, Brazil

  • Clinfan Szolgaltato Kft.

    Szekszárd, 7100, Hungary

  • Clinical Applications Laboratories

    San Diego, California, 92103, United States

  • Clinical Center " Dr Dragisa Misovic Dedinje"

    Belgrade, 11000, Serbia

  • Clinical Hospital Center "Bezanijska kosa

    Belgrade, Serbia

  • Clinical Hospital Center Zvezdara

    Belgrade, 11000, Serbia

  • Clinical Research Institute of Michigan, LLC

    Chesterfield, Michigan, 48047, United States

  • Cliniq s.r.o.

    Bratislava, 82007, Slovakia

  • Communal Enterprise Hospital #1 of Zhytomyr City Council

    Zhytomyr, Ukraine

  • Communal Enterprise Volyn Regional Clinical Hospital of Volyn Regional Council

    Lutsk, Ukraine

  • Complejo Hospitalario Universitario de Ferrol

    Ferrol, La Coruña, 15405, Spain

  • Connolly Hospital

    Abbotstown, Dublin, D15 X40D, Ireland

  • Consultorio Medico, InvesclinicMX

    Irapuato, Guanajuato, 36650, Mexico

  • Cotton O'Neil Clinical Research Center

    Topeka, Kansas, 66606, United States

  • DC-MED

    Swidnica, 58-100, Poland

  • DIM Clinica Privada

    Ramos Mejía, Buenos Aires, Argentina

  • DRK Kliniken Berlin Westend

    Berlin, 14050, Germany

  • Danbury Hospital

    Danbury, Connecticut, 06810, United States

  • Datta Meghe Institute of Medical Sciences (Deemed University)

    Wardha, Maharashtra, 442004, India

  • Diagnostic Consultation Center CONVEX EOOD

    Sofia, 1680, Bulgaria

  • Digestive Health Research, LC

    Hermitage, Tennessee, 37076, United States

  • Digestive System Healthcare

    Pasadena, Texas, 77505, United States

  • ETG Kielce Zagorska

    Kielce, 25-355, Poland

  • Ehime Prefectural Central Hospital

    Matsuyama, Ehime, 790-0024, Japan

  • Endomed, s.r.o.

    Košice, 04013, Slovakia

  • Evangelisches Krankenhaus Kalk GmbH

    Cologne, Germany

  • FAICIC S. de R.L. de C.V.

    Veracruz, 91900, Mexico

  • Fakultna nemocnica s poliklinikou F.D. Roosevelta

    Banská Bystrica, 97517, Slovakia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, 00168, Italy

  • Fortis Escorts Heart Institute and Research Centre

    New Delhi, National Capital Territory of Delhi, 110025, India

  • Frontier Clinical Research, LLC

    Uniontown, Pennsylvania, 15401, United States

  • Fukui Prefectural Hospital

    Fukui-shi, Japan

  • Fukuoka University Chikushi Hospital

    Chikushino-shi, Fukuoka, 818-8502, Japan

  • GCP Clinical Research, LLC

    Tampa, Florida, 33609, United States

  • GZA Ziekenhuizen

    Antwerp, 2018, Belgium

  • Gabinet Lekarski Bartosz Korczowski

    Rzeszów, 35-302, Poland

  • Galilee Medical Center Institute of Gastroenterology

    Nahariya, Israel

  • Gandhi Hospital

    Secunderabad, Andhra Pradesh, 500003, India

  • Gastro I, s.r.o.

    Prešov, 08001, Slovakia

  • Gastro LM s.r.o.

    Prešov, 08001, Slovakia

  • Gastroenterology Consultants and Endoscopy Center of Southwest Virginia

    Roanoke, Virginia, 24014, United States

  • Gastroenterology Consultants of South Texas, PA

    Harlingen, Texas, 78550, United States

  • Gastroenterología Diagnóstica y Terapéutica (Gedyt)

    Ciudad Autonoma Buenos Aires, C1117ABK, Argentina

  • General Hospital "Djordje Joanovic"

    Zrenjanin, Serbia

  • General Hospital Prim.dr.Abdulah Nakas

    Sarajevo, Bosnia and Herzegovina

  • General Hospital Subotica

    Subotica, 24000, Serbia

  • Gleneagles Global Hospitals

    Hyderabad, India

  • Gordon and Leslie Diamond Health Care Centre - Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Gujarat Hospital

    Surat, Gujarat, 395009, India

  • Guy's Hospital

    London, Greater London, SE1 9RT, United Kingdom

  • Gyongyosi Bugat Pal Korhaz

    Gyöngyös, 3200, Hungary

  • HUWC - UFC - Hospital Universitário Walter Cantídio - Universidade Federal do Ceará

    Fortaleza, Ceará, 60430-370, Brazil

  • HaEmek Medical Center

    Afula, 18101, Israel

  • Hamburgisches Forschungsinstitut fure Chronische Darmerkrankungen

    Hamburg, 20251, Germany

  • Hepatogastro

    São Paulo, São Paulo, 04543-011, Brazil

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, 92663, United States

  • Hopital Rangueil

    Toulouse, Haute Garonne, 31059, France

  • Hospital Aliança

    Salvador, Estado de Bahia, 41920-180, Brazil

  • Hospital Britanico de Buenos Aires

    Buenos Aires, Ciudad Autonoma Buenos Aires, C1280AEB, Argentina

  • Hospital Clinico Universitario de Valencia

    Valencia, 46010, Spain

  • Hospital General Juan Ramon Jimenez

    Huelva, 21005, Spain

  • Hospital Montecelo

    Pontevedra, 36071, Spain

  • Hospital Sirio Libanes

    São Paulo, Brazil

  • Hospital Universitario Miguel Servet

    Zaragoza, 50009, Spain

  • Hospital Universitario de Fuenlabrada

    Fuenlabrada, Madrid, 28942, Spain

  • Hospital Universitario de Gran Canaria Dr. Negrin

    Las Palmas de Gran Canaria, Las Palmas, 35019, Spain

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital de brabois

    Vandœuvre-lès-Nancy, Moselle, 57070, France

  • Hospital of Lithuanian University of Health Sciences Kaunas Clinics

    Kaunas, LT-50161, Lithuania

  • Hyogo Prefectural Harima-Himeji General Medical Center

    Himeji-shi, Japan

  • Hôpital Nord - CHU Marseille

    Marseille, Bouches-du-Rhône, 13915, France

  • IHS Health

    Kissimmee, Florida, 34741, United States

  • INLUGA im Haus der Gesundheit

    Ludwigshafen am Rhein, Rhineland-Palatinate, 67067, Germany

  • Indywidualna Specjalistyczna Praktyka Lekarska Maciej Zymla

    Knurów, 44-190, Poland

  • Inquest Clinical Research

    Baytown, Texas, 77521, United States

  • Institut des MICI

    Neuilly, Hauts De Seine, 92200, France

  • Institut klinicke a experimentalni mediciny

    Prague, 14021, Czechia

  • Institute of Post Graduate Medical Education And Research

    Kolkata, West Bengal, 700020, India

  • Institute of Science Tokyo Hospital

    Bunkyō City, Japan

  • Instituto de Pesquisas em Saúde - Fundação Universidade de Caxias do Sul (IPS/FUCS)

    Caxias do Sul, Rio Grande do Sul, 95070-560, Brazil

  • Irmandade da Santa Casa da Misericórdia de Santos

    Santos, São Paulo, 11075-101, Brazil

  • Isha Multispeciality Hospital

    Vadodara, Gujarat, 390007, India

  • Istituto Clinico Humanitas

    Rozzano, Milano, 20089, Italy

  • JCHO Hokkaido Hospital

    Sapporo, Hokkaido, 062-8618, Japan

  • JCHO Osaka Hospital

    Osaka, Osaka, 553-0003, Japan

  • JCHO Tokyo Yamate Medical Center

    Shinjuku-ku, Tokyo-To, 169-0073, Japan

  • Jiaikai Izuro Imamura Hospital

    Kagoshima, Kagoshima-ken, 892-0824, Japan

  • Juntendo University Hospital

    Bunkyō City, Japan

  • KM Management spol. s r.o.

    Nitra, 04901, Slovakia

  • Kagawa Prefectural Central Hospital

    Takamatsu, Kagawa-ken, 760-8557, Japan

  • Kagoshima IBD Gastroenterology Clinic

    Kagoshima, Kagoshima-ken, 892-0843, Japan

  • Kaiseikai Hattori Clinic

    Kumamoto, Kumamoto, 860-0004, Japan

  • Kaplan Medical Center KMC Institute of Gastroenterology and Liver Diseases

    Rehovot, 76100, Israel

  • Kawasaki Municipal Hospital

    Kawasaki-shi, Kanagawa, 210-0013, Japan

  • Keiaikai Nakagami Hospital

    Okinawa-shi, Okinawa, 904-2195, Japan

  • Keijinkai Matsushima Hospital

    Yokohama, Japan

  • Kiryu Kosei General Hospital

    Kiryu-shi, Gunma, 376-0024, Japan

  • Kitasato University Kitasato Institute Hospital

    Minatoku, Tokyo-To, 108-8642, Japan

  • Kokikai Tsujinaka Hospital Kashiwanoha

    Kashiwa-shi, Chiba, 277-0871, Japan

  • Krankenhaus Waldfriede e. V.

    Berlin, 14163, Germany

  • Kumagaya General Hospital

    Kumagaya-shi, Saitama, 360-8567, Japan

  • Kurume University Hospital

    Kurume-shi, Fukuoka, 830-0011, Japan

  • Kyorin University Hospital

    Mitaka-shi, Japan

  • L2IP - Instituto de Pesquisas Clínicas Ltda.

    Brasília, Federal District, 70200-730, Brazil

  • LinQ Research, LLC

    Pearland, Texas, 77584, United States

  • Lithuanian University of Health Sciences Kaunas Hospital

    Kaunas, 47144, Lithuania

  • Lokmanya Tilak Municipal General Hospital & Medical College

    Mumbai, Maharashtra, 400022, India

  • London Health Sciences Centre (LHSC) - Victoria Hospital

    London, Canada

  • M.V. Sklifosovskyi Poltava RCH Dept of Pulmonology HSEIU Ukrainian Medical Stomatological Academy

    Poltava, Ukraine

  • MC Medica Plus

    Veliko Tarnovo, 5000, Bulgaria

  • Maharaja Agrasen Hospital

    New Delhi, National Capital Territory of Delhi, 110026, India

  • Matsuaikai Matsuda Hospital

    Hamamatsu, Shizuoka, 432-8061, Japan

  • Medical Center Universal Clinic Oberih of Limited Liability Company Kapital

    Kyiv, Ukraine

  • Medical Center of Limited Liability Company Arensia Exploratory Medicine

    Kyiv, Ukraine

  • Medical Center of Limited Liability Company Medical Center Clinic of Family Medicine

    Dnipro, Ukraine

  • Medicome Sp. z o.o.

    Oświęcim, 32-600, Poland

  • Meir Medical Center

    Kfar Saba, 4428164, Israel

  • Midland Regional Hospital

    Mullingar, Westmeath, N91, Ireland

  • Mount Sinai

    New York, New York, 10029, United States

  • NHI Komatsu Municipal Hospital

    Komatsu-shi, Japan

  • NHO Fukuyama Medical Center

    Fukuyama-shi, Hiroshima, 720-8520, Japan

  • NHO Hirosaki General Medical Center

    Hirosaki-shi, Japan

  • NHO Kanazawa Medical Center

    Kanazawa, Ishikawa-ken, 920-8650, Japan

  • NHO Kure Medical Center and Chugoku Cancer Center

    Kure-shi, Hiroshima, 737-0023, Japan

  • NHO Okayama Medical Center

    Okayama, Okayama-ken, 701-1192, Japan

  • NHO Osaka National Hospital

    Osaka, Osaka, 540-0006, Japan

  • NHO Ureshino Medical Center

    Ureshino-shi, Saga-ken, 843-0393, Japan

  • NY Scientific Corp.

    Brooklyn, New York, 11235, United States

  • NZOZ Centrum Medyczne KERmed

    Bydgoszcz, 85-231, Poland

  • NZOZ Neuromed M. i M. Nastaj Sp.P.

    Lublin, Poland

  • Nagaoka Red Cross Hospital

    Nagaoka-shi, Japan

  • National Institute of Clinical Research

    Bakersfield, California, 93309, United States

  • Newfoundland and Labrador Health Services

    Winnipeg, Manitoba, Canada

  • Nowe zdrowie-CK, Kieltucki i wspolnicy sp. j.

    Staszów, 28-200, Poland

  • Okayama University Hospital

    Okayama, Okayama-ken, 700-8558, Japan

  • Omega Research Orlando, LLC

    Orlando, Florida, 32808, United States

  • Origin Hospital

    Hyderabad, Andhra Pradesh, 500048, India

  • Osaka Medical and Pharmaceutical University Hospital

    Takatsuki-shi, Japan

  • Our Lady of the Snow St. Mary's Hospital

    Kurume-shi, Fukuoka, 830-8543, Japan

  • Pesquisare Saúde

    Santo André, São Paulo, 09080-110, Brazil

  • Plains Clinical Research Center, LLC

    Fargo, North Dakota, 58104, United States

  • Poliklinika Borzan d.o.o

    Osijek, 31000, Croatia

  • Portiuncula Hospital

    Galway, Ireland

  • Praxis Pesquisa Medica

    Santo André, São Paulo, 09090-970, Brazil

  • Premier Health Research

    Sparta, New Jersey, 07871, United States

  • RCNECRCH Dept of Proctology, SHEI Ukr BSMU

    Chernivtsi, Ukraine

  • Rabin Medical Center-Beilinson Campus

    Petah Tikva, 4941492, Israel

  • Railway Transport Kyiv Clinical Hospital #2 of Healthcare Center Branch of JSC Ukrainian Railway

    Kyiv, Ukraine

  • Rapid City Medical Center, LLC

    Rapid City, South Dakota, 57701, United States

  • Research Associates of South Florida

    Miami, Florida, 33134, United States

  • Research Solutions of Arizona, PC

    Litchfield Park, Arizona, 85340, United States

  • Richmond VA Medical Center

    Richmond, Virginia, 23249, United States

  • S.C Centrul Medical Valahia S.R.L

    Ploieşti, 100550, Romania

  • S.C Pelican Impex S.R.L

    Oradea, 410469, Romania

  • SC Centrul Medical Medicum SRL, Specialitatea Gastroenterologie

    Bucharest, 012015, Romania

  • SSH St. Panteleimon of MNPE "Lviv Territorial Med Union" MC of E&I care,Th. Center D.Halytskyi LNMU

    Lviv, Ukraine

  • SUBARU Health Insurance Society Ota Memorial Hospital

    Ota-shi, Gunma, 373-8585, Japan

  • Saga University Hospital

    Saga, Saga-ken, 849-8501, Japan

  • Saga-Ken Medical Centre Koseikan

    Saga, Saga-ken, 840-8571, Japan

  • Saiseikai Niigata Hospital

    Niigata, Niigata, 950-1104, Japan

  • Sameshima Hospital

    Kagoshima, Kagoshima-ken, 892-0846, Japan

  • Sanchez Clinical Research, Inc

    Miami, Florida, 33157, United States

  • Santa Maria Gastroenterology Medical Group

    Santa Maria, California, 93458, United States

  • Sarkis Clinical Trials - Parent

    Ocala, Florida, 34474, United States

  • Semmelweis Egyetem

    Budapest, 1088, Hungary

  • Shaare Zedek Medical Center

    Jerusalem, 9103102, Israel

  • Shinseikai Sai Gastroenterology, Proctology Clinic

    Fujiidera, Osaka, 583-0027, Japan

  • Showa University Koto Toyosu Hospital

    Kōtoku, Tokyo-To, 135-8577, Japan

  • Showa University Northern Yokohama Hospital

    Yokohama, Kanagawa, 224-8503, Japan

  • Siloah St. Trudpert Klinikum

    Pforzheim, Germany

  • Sociedad de Metabolismo y Corazon S.C

    Veracruz, 91900, Mexico

  • Somogy Varmegyei Kaposi Mor Oktato Korhaz

    Kaposvár, 7400, Hungary

  • Soroka University Medical Center

    Beersheba, 84001, Israel

  • Southern Star Research Institute, LLC

    San Antonio, Texas, 78229, United States

  • Spitalul Clinic Colentina

    Bucharest, 020125, Romania

  • Spitalul Clinic Judetean de Urgenta Cluj Napoca

    Cluj-Napoca, 400006, Romania

  • Spitalul de Oncologie Monza

    Bucharest, 013812, Romania

  • St Vincents University Hospital

    Dublin, Ireland

  • Surat Institute of Digestive Sciences

    Surat, Gujarat, 395002, India

  • Susquehanna Research Group, LLC

    Harrisburg, Pennsylvania, 17110, United States

  • Svet zdravia a.s.

    Rimavská Sobota, 97901, Slovakia

  • Takamatsu Red Cross Hospital

    Takamatsu, Kagawa-ken, 760-0017, Japan

  • Tandem Clinical Research, LLC

    Marrero, Louisiana, 70072, United States

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • Texas Clinical Research Institute, LLC

    Arlington, Texas, 76012, United States

  • The University of Iowa

    Iowa City, Iowa, 52242, United States

  • The Vancouver Clinic

    Vancouver, Washington, 98664, United States

  • Tokyo Metropolitan Bokutoh Hospital

    Sumida-ku, Japan

  • Trialmed CRS

    Piotrkow Trybunalski, 62-800, Poland

  • Tyler Research Institute, LLC

    Tyler, Texas, 75703, United States

  • UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu

    Botucatu, São Paulo, 18618-686, Brazil

  • United Medical Doctors

    Murrieta, California, 92563, United States

  • Universitaetsklinikum Tuebingen

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Universitaetsklinikum Ulm

    Ulm, Germany

  • Universitair Ziekenhuis Gent

    Ghent, 9000, Belgium

  • University Clinical Center Kragujevac

    Kragujevac, Serbia

  • University Clinical Center Tuzla

    Tuzla, Bosnia and Herzegovina

  • University Clinical Centre of the Republic of Srpska

    Banja Luka, Bosnia and Herzegovina

  • University hospital centre Zagreb

    Zagreb, 10000, Croatia

  • University of Alabama -Birmingham

    Birmingham, Alabama, 35205, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • University of South Florida - PARENT

    Tampa, Florida, 33612, United States

  • Università Campus Bio-Medico di Roma

    Roma, 00128, Italy

  • Vydehi Institute of Medical Sciences and Research Centre

    Bengaluru, India

  • Waikato Hospital

    Hamilton, 3200, New Zealand

  • Wellness Clinical Research

    Miami Lakes, Florida, 33016, United States

  • West Central Gastroenterology d/b/a Gastro Florida

    Clearwater, Florida, 33762, United States

  • Wojewodzki Specjalistyczny Szpital w Olsztynie

    Olsztyn, 10-561, Poland

  • Wolfson Medical Center

    Holon, Israel

  • Yashoda Super Speciality Hospital

    Hyderabad, Andhra Pradesh, 500082, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.